108 related articles for article (PubMed ID: 7341111)
1. [Investigation on the relationship between HBsAg and primary hepatic cancer (PHC) in households in areas of low risk to PHC (author's transl)].
Li GY
Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Sep; 15(5):296-8. PubMed ID: 7341111
[No Abstract] [Full Text] [Related]
2. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
Lu P; Wang J; Wu Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
[TBL] [Abstract][Full Text] [Related]
3. [Some epidemiologic characteristics of HBsAg in saliva (author's transl)].
Jing Q
Zhonghua Yu Fang Yi Xue Za Zhi; 1980 May; 14(2):109-11. PubMed ID: 7215029
[No Abstract] [Full Text] [Related]
4. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
5. [A causative factors study on primary hepatogenosis cancer (PHC)].
Ye BF
Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Dec; 9(6):350-3. PubMed ID: 3245963
[No Abstract] [Full Text] [Related]
6. [The relationship between primary liver cancer (PLC) and surface antigens of hepatitis B virus].
Yu SZ
Zhonghua Yu Fang Yi Xue Za Zhi; 1986 Mar; 20(2):70-2. PubMed ID: 3769661
[No Abstract] [Full Text] [Related]
7. [Severe neonatal hepatitis B transmitted by asymptomatic carrier mother (author's transl)].
Ruiz Extremera A; Salmerón Escobar FJ; Loscertales Abril M; López Cueto A; Hernández Gómez MV; Bernal Zamora C; Molina Font JA
An Esp Pediatr; 1981 Sep; 15(3):284-8. PubMed ID: 7332140
[No Abstract] [Full Text] [Related]
8. [The importance of HBsAg in differential diagnosis of virus hepatitis (author's transl)].
Janout V; Sedlácek V; Chobot S; Walderová O; Sajdák E; Hofta J; Fierla T; Galetková A; Sekerová Z; Cechová D; Bindas B
Cesk Epidemiol Mikrobiol Imunol; 1980 May; 29(3):151-9. PubMed ID: 6446412
[No Abstract] [Full Text] [Related]
9. [Preliminary studies on HBsAg excretion from saliva in healthy carriers and epidemiological pattern of hepatitis B (author's transl)].
Cao HL; Wang FL; Du XL; Chen SX; Wang Y; Liu CB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):179-82. PubMed ID: 6459179
[No Abstract] [Full Text] [Related]
10. [Plasma alpha--fetoprotein in different liver diseases and in the primary carcinoma of the liver (author's transl)].
Jorge AD; Diáz M; Sánchez D; Tanne H; Roncoroni M; Fay O
Rev Med Chil; 1975 Jan; 103(1):1-3. PubMed ID: 79204
[No Abstract] [Full Text] [Related]
11. [Etiologic fraction and interaction of risk factors for primary hepatocellular carcinoma in Wenzhou, Zhejiang Province].
Zou CL; Chen ZJ; Jin WY; Ni SC; Chen BF; Hu YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):355-7. PubMed ID: 14680600
[TBL] [Abstract][Full Text] [Related]
12. [Discharge of HBsAg in saliva and its epidemiological significance (author's transl)].
Ma WG
Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Sep; 15(5):307-9. PubMed ID: 7341114
[No Abstract] [Full Text] [Related]
13. [The importance of IgM anti-HAV test in hepatitis evaluation (author's transl)].
Iosa G; Turci F; Cipolloni AP; Cenciotti L
Quad Sclavo Diagn; 1981 Sep; 17(3):289-93. PubMed ID: 7343983
[No Abstract] [Full Text] [Related]
14. [The occurrence of HBsAg in different groups of population (author's transl)].
Cervenka J; Zacharová M; Mruskovicová L; Fedorová L
Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):65-9. PubMed ID: 6452957
[No Abstract] [Full Text] [Related]
15. [The retrospective analysis of the epidemic of the "infections hepatitid" in 1964 (author's transl)].
Cervenka J; Mruskovicová L; Littvová M; Glasnák I; Kristofík A
Cesk Epidemiol Mikrobiol Imunol; 1980 May; 29(3):133-42. PubMed ID: 6446410
[No Abstract] [Full Text] [Related]
16. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of viral hepatitis B in exposure to carriers of HBsAG in Plzen in 1998].
Pazdiora P; Petríková V; Fránová D
Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):153-9. PubMed ID: 10658343
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal.
Dutta S; Shivananda PG; Chatterjee A
Indian J Public Health; 1994; 38(3):108-12. PubMed ID: 7774971
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital.
Baba MM; Ajayi BB; Ekanem IA
Niger Postgrad Med J; 2000 Sep; 7(3):91-5. PubMed ID: 11257921
[TBL] [Abstract][Full Text] [Related]
20. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
Gidding HF; Warlow M; MacIntyre CR; Backhouse J; Gilbert GL; Quinn HE; McIntyre PB
Vaccine; 2007 Dec; 25(51):8637-41. PubMed ID: 18054127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
